- Previous: Antibody Isolation May Prevent or Slow HCV
- Main
- Next: Trial to Test Potential HCV Triple Combination Therapy
New HCV Drug Prospect Gets Good Marks for Safety
December 24, 2007
Already approved in the Russian Federation for treating Hepatitis B and C, NOV-205 has just demonstrated its safety in a U.S. Phase 1b trial. As we progress into 2008, look for reports on the efficacy of this drug.
Novelos ends safety trial of hep C drug on good news
Mass High Tech: The Journal of New England Technology
Thursday, December 13, 2007
www.bizjournals.com
Novelos Therapeutics Inc. reports concluding its initial U.S.-based Phase 1b trial for a hepatitis C therapy with good safety results.
The Newton-based biopharmaceutical company was evaluating NOV-205 as a therapy in chronic hepatitis C genotype 1 patients who had previously failed treatment with interferon plus ribavirin.
Based on favorable safety data in the 14-dose trial with 18 subjects, Novelos said it plans to initiate a longer proof-of-concept trial in hepatitis C nonresponders during the second half of 2008.
NOV-205 has been approved in the Russian Federation, based on a longer duration of dosing in treating hepatitis B and C patients who have not yet received other treatments. NOV-205 was also tolerated well in those studies, officials said.
According to the World Health Organization, chronic hepatitis C affects 170 million people worldwide and up to 4 million people are newly infected each year. Chronic infection can progress to cirrhosis, end-stage liver disease and hepatocellular carcinoma.
Posted by Editors at December 24, 2007 12:06 PM
Site Topics
HCV Symptoms
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Lab Tests
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Hepatitis C Genotypes
Learn about Hepatitis C Genotypes and their variants.
Viral Load
Includes a convenient Viral Load chart, as well as a link to a detailed discussion on how to analyze and interpret viral load numbers.
What is...?
Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.
HCV Medicines
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Hepatitis C Doctors
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
Biopsy Info
A comprehensive resource of information relating to the liver biopsy.
Cirrhosis
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
Liver Cancer
Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.
Liver Disease Medicines
An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.
Hep-Central Email List
Sign up to learn about advances and breakthroughs in Hepatitis C research, including information about medical and complementary treatments.
HCV Links
Convenient links to other sites external to Hepatitis-Central.
Mother/Child Transmission
Discussions of the special problems and precautions necessary involving mother to child transmission of Hepatitis C.
HCV Natural Remedies
A number of herbal products useful in the management of liver disease.
HCV Books
Recommended reading for those interested in hepatitis information.
Hepatitis C Forum
A Bulletin Board for discussions on hepatitis, treatments, etc.
Hepatitis C Activism
An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.
Advertisement
Advertisement
Site Topics
HCV Symptoms, Lab Tests, Hepatitis C Genotypes, Glossary, Viral Load, What is...?, HCV Medicines, Hepatitis C Doctors, Biopsy Info, Cirrhosis, Liver Cancer, Liver Disease Medicines, Hep-Central Email List, HCV Links, Mother / Child Transmission, HCV Natural Remedies, HCV Books, Hepatitis C Forum, Hepatitis C Activism
Copyright ©1994-2010 Hepatitis Central. Information at this website is for educational purposes only; statements about products and health conditions have not been evaluated by the U.S. Food & Drug Administration.